Company: HCWB
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0000950170-25-058961
Chunk: 44

Company: HCW Biologics Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 44
---
.0001 par value per share, at a purchase price of $1.40 per share for an aggregate purchase price of $2.5 million. This preceded the reverse stock split, which occurred on April 11, 2025, whereby the Company effected a one-for-forty reverse stock split of its common stock, par value $0.0001. The reverse stock split is not reflected in the private placement disclosure below. The following table summarizes the common stock purchased by our directors, executive officers, and beneficial owners of more than 5% of common stock.

| Name and Title                             | Shares of Common Stock |         |     | Total Purchase Price |              |
|:-------------------------------------------|:-----------------------|--------:|:----|:---------------------|-------------:|
| Rebecca Byam, Chief Financial Officer      |                        | 760,714 |     | $                    | 1,064,999.60 |
| Dr. Hing C. Wong, Chief Executive Officer* |                        | 739,288 |     | $                    | 1,035,003.20 |
| Scott Garrett, Chairman of the Board       |                        | 142,858 |     | $                    |   200,001.20 |

____ * Beneficial owner of more than 5% of the Common Stock The shares have not been registered and will not be sold or transferred except as permitted under law and pursuant to registration or exemption therefrom. The Board of Directors and Audit Committee of the Board of Directors reviewed the transaction under the policy for Related Party Transactions and determined that the transaction was in compliance with such policy. Secured Note Financing On March 28, 2024, we entered into a senior secured note purchase agreement with certain purchasers, pursuant to which we agreed to issue senior secured notes in an aggregate principal amount of $10.0 million (the “Secured Notes”) to certain accredited investors. We issued an aggregate principal amount of $6.9 million in Secured Notes prior to the issuance through October 31, 2024. The following table summarizes the aggregate principal amounts of Secured Notes purchased by our directors, executive officers, and beneficial owners of more than 5% of common stock at par.

| Name and Title                                    | Aggregate Principal     
 Amount of Secured Notes |           |
|:--------------------------------------------------|:------------------------|----------:|
| Dr. Hing C. Wong, Chief Executive Officer*        | $                       | 2,405,000 |
| Rebecca By